Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares RepurchasedWages, Salaries and Other
Ratios

Neuraxis (NRXS) EBIAT (2022 - 2025)

Neuraxis (NRXS) has disclosed EBIAT for 4 consecutive years, with -$1.7 million as the latest value for Q4 2025.

  • Quarterly EBIAT fell 18.01% to -$1.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$7.8 million through Dec 2025, up 5.35% year-over-year, with the annual reading at -$7.8 million for FY2025, 5.35% up from the prior year.
  • EBIAT hit -$1.7 million in Q4 2025 for Neuraxis, up from -$2.1 million in the prior quarter.
  • In the past five years, EBIAT ranged from a high of -$13628.0 in Q4 2022 to a low of -$8.6 million in Q3 2023.
  • Historically, EBIAT has averaged -$2.3 million across 4 years, with a median of -$2.1 million in 2022.
  • Biggest five-year swings in EBIAT: plummeted 11584.02% in 2023 and later skyrocketed 79.65% in 2024.
  • Year by year, EBIAT stood at -$13628.0 in 2022, then tumbled by 11584.02% to -$1.6 million in 2023, then rose by 9.07% to -$1.4 million in 2024, then fell by 18.01% to -$1.7 million in 2025.
  • Business Quant data shows EBIAT for NRXS at -$1.7 million in Q4 2025, -$2.1 million in Q3 2025, and -$1.7 million in Q2 2025.